Synergistic chemotherapy/PTT/oxygen enrichment by multifunctional liposomal polydopamine nanoparticles for rheumatoid arthritis treatment

Abstract

Amultifunctional liposomal polydopamine nanoparticle (MPM@Lipo) was designed in this study, to combine chemotherapy, photothermal therapy (PTT) and oxygen enrichment to clear hyperproliferating inflammatory cells and improve the hypoxic microenvironment for rheumatoid arthritis (RA) treatment. MPM@Lipo significantly scavenged intracellular reactive oxygen species and relieved joint hypoxia, thus contributing to the repolarization of M1 macrophages into M2 phenotype. Furthermore, MPM@Lipo could accumulate at inflammatory joints, inhibit the production of inflammatory factors, and protect cartilage in vivo, effectively alleviating RA progression in a rat adjuvant-induced arthritis model. Moreover, upon laser irradiation, MPM@Lipo can elevate the temperature to not only significantly obliterate excessively proliferating inflammatory cells but also accelerate the production of methotrexate and oxygen, resulting in excellent RA treatment effects. Overall, the use of synergistic chemotherapy/PTT/oxygen enrichment therapy to treat RA is a powerful potential strategy.

Graphical abstract

Keywords

Polydopamine / Thermosensitive liposomes / Photothermal therapy / Oxygen generation / Rheumatoid arthritis

Conflicts of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Supplementary materials

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.ajps.2024.100885.

References

[1] Wang S, Chen R, Yu Q, Huang W, Lai P, Tang J, et al. Near-infrared plasmon-boosted heat/oxygen enrichment for reversing rheumatoid arthritis with metal/semiconductor composites. ACS Appl Mater Interfaces 2020;12:45796-806.

[2] Zhang G, Sun G, Guan H, Li M, Liu Y, Tian B, et al. Naringenin nanocrystals for improving anti-rheumatoid arthritis activity. Asian J Pharm Sci 2021;16:816-25.

[3] Li Y, Liang Q, Zhou L, Cao Y, Yang J, Li J, et al. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomater 2022;152:406-24.

[4] Tian J, Chen T, Huang B, Liu Y, Wang C, Cui Z, et al. Inflammation specific environment activated methotrexate-loaded nanomedicine to treat rheumatoid arthritis by immune environment reconstruction. Acta Biomater 2023;157:367-80.

[5] Guo T, Kang X, Ren S, Ouyang X, Chang M. Construction of a nano-controlled release methotrexate delivery system for the treatment of rheumatoid arthritis by local percutaneous administration. Nanomaterials 2021;11:2812.

[6] Wang Q, Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci 2017;5:1407-20.

[7] Chen X, Zhu X, Xu T, Xu M, Wen Y, Liu Y, et al. Targeted hexagonal Pd nanosheet combination therapy for rheumatoid arthritis via the photothermal controlled release of MTX. J Mater Chem B 2019;7:112-22.

[8] Yang N, Li M, Wu L, Song Y, Yu S, Wan Y, et al. Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis. J Nanobiotechnology 2023;21.

[9] Feng C, Pan L, Qin X, Li D, Chen T, Lin Z, et al. Inflammation-homing “living drug depot” for efficient arthritis treatment. Acta Biomater 2022;150:324-36.

[10] Vanniasinghe AS, Manolios N, Schibeci S, Lakhiani C, Kamali-Sarvestani E, Sharma R, et al. Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. Clin Immunol 2014;151:43-54.

[11] Yang Y, Luo S, Peng X, Zhao T, He Q, Wu M, et al. An intra-articular injectable phospholipids-based gel for the treatment of rheumatoid arthritis. Asian J Pharm Sci 2023;18:100777.

[12] Kim J, Kim HY, Song SY, Go S-h, Sohn HS, Baik S, et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano 2019;13:3206-17.

[13] Liu X, Guo R, Huo S, Chen H, Song Q, Jiang G, et al. CaP-based anti-inflammatory HIF-1α siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy. J Control Release 2022;343:314-25.

[14] Ma Q, Bai J, Xu J, Dai H, Fan Q, Fei Z, et al. Reshaping the inflammatory environment in rheumatoid arthritis joints by targeting delivery of berberine with platelet-derived extracellular vesicles. Adv Nanobiomed Res 2021;1:2100071.

[15] Lu Y, Li L, Lin Z, Wang L, Lin L, Li M, et al. A new treatment modality for rheumatoid arthritis: combined photothermal and photodynamic therapy using Cu7.2S4 nanoparticles. Adv Healthc Mater 2018;7:1800013.

[16] Huang R, Zhang C, Bu Y, Li Z, Zheng X, Qiu S, et al. A multifunctional nano-therapeutic platform based on octahedral yolk-shell Au NR@CuS: photothermal/ photodynamic and targeted drug delivery tri-combined therapy for rheumatoid arthritis. Biomaterials 2021;277: 121088.

[17] Gadeval A, Chaudhari S, Bollampally SP, Polaka S, Kalyane D, Sengupta P, et al. Integrated nanomaterials for non-invasive photothermal therapy of rheumatoid arthritis. Drug Discov Today 2021;26:2315-28.

[18] Lu J, Cai L, Dai Y, Liu Y, Zuo F, Ni C, et al. Polydopamine-based nanoparticles for photothermal therapy/chemotherapy and their synergistic therapy with autophagy inhibitor to promote antitumor treatment. Chem Rec 2021;21:781-96.

[19] Yu H, Fan J, Shehla N, Qiu Y, Lin Y, Wang Z, et al. Biomimetic hybrid membrane-coated xuetongsu assisted with laser irradiation for efficient rheumatoid arthritis therapy. ACS Nano 2021;16:502-21.

[20] Wei Y, Nie Y, Han Z, Huang H, Liao X, Wang X, et al. Au@polydopamine nanoparticles/tocilizumab composite as efficient scavengers of oxygen free radicals for improving the treatment of rheumatoid arthritis. Mater Sci Eng: C 2021;118:111434.

[21] Liu S, Zhang C, Zhou Y, Zhang F, Duan X, Liu Y, et al. MRI-visible mesoporous polydopamine nanoparticles with enhanced antioxidant capacity for osteoarthritis therapy. Biomaterials 2023;295:122030.

[22] Zhao H, Zeng Z, Liu L, Chen J, Zhou H, Huang L, et al. Polydopamine nanoparticles for the treatment of acute inflammation-induced injury. Nanoscale 2018;10:6981-91.

[23] Bao X, Zhao J, Sun J, Hu M, Yang X. Polydopamine nanoparticles as efficient scavengers for reactive oxygen species in periodontal disease. ACS Nano 2018;12:8882-92.

[24] Huang X, He D, Pan Z, Luo G, Deng J. Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation. Materials Today Bio 2021;11:100124.

[25] Li C, Zhao Z, Luo Y, Ning T, Liu P, Chen Q, et al. Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke. Adv Sci 2021;8:2101526.

[26] Wu C, Cheng J, Li W, Yang L, Dong H, Zhang X. Programmable polymeric microneedles for combined chemotherapy and antioxidative treatment of rheumatoid arthritis. ACS Appl Mater Interfaces 2021;13:55559-68.

[27] Liu Y, Xu J, Liu L, Tan J, Gao L, Wang J, et al. Amorphous manganese dioxide coated polydopamine nanoparticles for acid-sensitive magnetic resonance imaging-guided tumor photothermal therapy. J Biomed Nanotechnol 2019;15:1771-80.

[28] Zhang H, Tang W-L, Kheirolomoom A, Fite BZ, Wu B, Lau K, et al. Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy. J. Contro. Release 2021;330:1080-94.

[29] Jose A, Ninave KM, Karnam S, Venuganti VVK. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment. J Liposome Res 2018;29:153-62.

[30] Zhao J, Zhao M, Yu C, Zhang X, Liu J, Cheng X, et al. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomedicine 2017;12:6735-46.

[31] Daraghmeh DN, Moghaddami M, Bobrovskaya L, Proudman SM, Wiese MD. Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC-MS/MS-based method. Anal. Bioanal. Chem. 2022;414:6029-46.

[32] Hu Q, Fu X, Dong Y, Ma J, Hua J, Li J, et al. d-optimal design and development of a koumine-loaded microemulsion for rheumatoid arthritis treatment: in vivo and in vitro evaluation. Int J Nanomedicine 2023;18:2973-88.

[33] Chen X, Zhu X, Ma L, Lin A, Gong Y, Yuan G, et al. A core-shell structure QRu-PLGA-RES-DS NP nanocomposite with photothermal response-induced M2 macrophage polarization for rheumatoid arthritis therapy. Nanoscale 2019;11:18209-23.

[34] Xi Y, Xie X, Peng Y, Liu P, Ding J, Zhou W. DNAzyme-adsorbed polydopamine@MnO2 core-shell nanocomposites for enhanced photothermal therapy via the self-activated suppression of heat shock protein 70. Nanoscale 2021;13:5125-35.

[35] Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 2020;16:316-33.

[36] Li B, Liu F, Ye J, Cai X, Qian R, Zhang K, et al. Regulation of macrophage polarization through periodic photo-thermal treatment to facilitate osteogenesis. Small 2022;18:2202691.

[37] Li Y, Zhai Y, Liu W, Zhang K, Liu J, Shi J, et al. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor. J Nanobiotechnology 2019;17.

[38] Zhang L, Qin Z, Sun H, Chen X, Dong J, Shen S, et al. Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact Mater 2022;18:1-14.

[39] Zheng C, Wu A, Zhai X, Ji H, Chen Z, Chen X, et al. The cellular immunotherapy of integrated photothermal anti-oxidation Pd-Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis. Acta Pharm Sin B 2021;11:1993-2003.

[40] Li G, Zhang Y, Liu D, Qian Y, Zhang H, Guo S, et al. PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial-mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis. Mol. Cell. Biochem. 2012;372:221-31.

[41] Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C. Akt signaling pathway in macrophage activation and M1/M2 polarization J Immunol 2017;198:1006-14.

[42] Ao L, Gao H, Jia L, Liu S, Guo J, Liu B, et al. Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3K/Akt signaling pathway. Mol Immunol 2022;141:13-20.

[43] Lin Y, Zheng F, Xiong B, Chen Z, Chen S, Fang C, et al. Koumine alleviates rheumatoid arthritis by regulating macrophage polarization. J Ethnopharmacol 2023;311:116474.

[44] Chen M, Lu Q, Chen Y, Hou Y, Zou Y-M, Zhou Q, et al. NIR-PTT/ROS-scavenging/oxygen-enriched synergetic therapy for rheumatoid arthritis by a pH-responsive hybrid CeO2-ZIF-8 coated with polydopamine. ACS Biomater Sci Eng 2022;8:3361-76.